Jacob Isichei-Kizito

New Zealand may finally get funded access to diabetes drugs which reduce cardiovascular events and progression of kidney disease: an audit of proposed PHARMAC criteria compared with international guidelines.

J. Krebs, R. Hall, B. Moss, 2020, The New Zealand medical journal.